Pacific Biosciences of California Inc. buy Stephens
Start price
15.05.25
/
50%
€0.94
Target price
15.05.26
€1.61
Performance (%)
92.84%
Price
12.12.25
€1.81
Summary
This prediction is currently active. With a performance of 92.84% the BUY prediction by Stephens is a big success. This prediction currently runs until 15.05.26. The prediction end date can be changed by Stephens at any time. Stephens has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Pacific Biosciences of California Inc. | -11.998% | -11.998% |
| iShares Core DAX® | 0.734% | -0.964% |
| iShares Nasdaq 100 | -2.686% | -2.409% |
| iShares Nikkei 225® | -2.261% | -4.038% |
| iShares S&P 500 | -1.346% | -1.510% |
Comments by Stephens for this prediction
In the thread Pacific Biosciences of California Inc. diskutieren
Pacific Biosciences of California, Inc. (NASDAQ: PACB) had its "overweight" rating re-affirmed by analysts at Stephens. They now have a $1.80 price target on the stock.
Ratings data for PACB provided by MarketBeat
Stopped prediction by Stephens for Pacific Biosciences of California Inc.
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.56
10.11.25
10.11.25
€1.73
10.11.26
10.11.26
15.82%
12.12.25
12.12.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€1.61
14.02.25
14.02.25
€2.38
14.02.26
14.02.26
12.73%
12.12.25
12.12.25
Pacific Biosciences of California Inc.
Start price
Target price
Perf. (%)
€8.42
14.12.23
14.12.23
€10.05
14.12.24
14.12.24
-77.24%
15.12.24
15.12.24